Sort
39,280 grants matching “leukemia”
Targeted Therapy for Leukemia
$971,232John C Byrd · University Of Cincinnati · R35 · FY2021 · CA
Office of Cancer Genomics
$970,411Douglas R. Lowy · Office Of The Director, Nci · ZIA · FY2011 · CA
Biological Functions of Chromosomal Proteins
$969,817Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
NMR Research Core Facility
$969,238Geoffrey Mueller · National Institute Of Environmental Health Sciences · ZIC · FY2023 · ES
Bioinformatic Tools in Cancer Research
$969,012Kenneth Buetow · Division Of Basic Sciences - Nci · ZIH · FY2009 · CA
MOLECULAR TAXONOMY OF PEDIATRIC AND ADULT ACUTE LEUKEMIA
$968,682University Of New Mexico · U01 · FY2003 · CA
Oncogenic NOTCH Signaling
$968,589Jon C Aster · Brigham And Women'S Hospital · P01 · FY2007 · CA
Modeling HIV CAR-T cell trafficking and persistence in Non-Human Primates
$968,416Hans-Peter Kiem · University Of Pennsylvania · U19 · FY2021 · AI
Novel enzyme inhibitor screening platform using modified designer nucleosomes
$968,299Zu-Wen Sun · Epicypher, Inc. · R44 · FY2020 · GM
Novel enzyme inhibitor screening platform using modified designer nucleosomes
$968,299Zu-Wen Sun · Epicypher, Inc. · R44 · FY2019 · GM
OSU as a Network Lead Academic Participating Site for the NCI NCTN
$968,250Claire F Verschraegen · Ohio State University · UG1 · FY2023 · CA
CANCER AND INFLAMMATION: FUNCTION AND THERAPY
$968,200Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
CANCER AND INFLAMMATION GENETICS
$968,200Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Occupational Exposure Assessment
$967,268Melissa Friesen · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA
Mechanisms of nonsense-mediated mRNA decay target selection
$967,080John Hogg · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
Understanding Hemotopoietic Neoplasias using Humanized Mice
$966,410Richard A Flavell · Yale University · R01 · FY2014 · CA
Targeting the MYC Pathway for the Treatment of Cancer
$965,767Dean W Felsher · Stanford University · R35 · FY2025 · CA
Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy
$965,559Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Hematopoiesis from Normal and Patient-Derived Induced Pluripotent Stem Cells
$964,802Mitchell J Weiss · Children'S Hosp Of Philadelphia · RC2 · FY2010 · HL
Hematopathology Diagnosis
$964,476Elaine Jaffe · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Genome-Wide Predictors of Treatment-Related Toxicities
$964,435Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2012 · CA
Metabolic control of normal and malignant hematopoiesis
$964,128Andrew Michael Intlekofer · Sloan-Kettering Inst Can Research · R37 · FY2025 · CA
NMR Research Core Facility
$963,802Geoffrey Mueller · National Institute Of Environmental Health Sciences · ZIC · FY2022 · ES
Targeting the MYC Pathway for the Treatment of Cancer
$963,300Dean W Felsher · Stanford University · R35 · FY2021 · CA
Comparative Biomedical Scientist Training Program
$963,134Robert Simpson · Division Of Basic Sciences - Nci · ZIG · FY2015 · CA